Pain gives back

Pain Therapeutics Inc. (NASDAQ:PTIE) believes payments for pain candidate Remoxy from partner Pfizer Inc. (NYSE:PFE) and its existing cash give the biotech more than enough runway to move an Alzheimer's disease diagnostic to the next inflection point. The company has thus decided to return about $34 million to investors.